.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Fish and Richardson
Cerilliant
Federal Trade Commission
Farmers Insurance
Covington
McKesson
Daiichi Sankyo
US Department of Justice
Medtronic

Generated: July 27, 2017

DrugPatentWatch Database Preview

Podofilox - Generic Drug Details

« Back to Dashboard

What are the generic sources for podofilox and what is the scope of podofilox freedom to operate?

Podofilox
is the generic ingredient in two branded drugs marketed by Paddock Llc, Allergan Sales Llc, and Bausch And Lomb Inc, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for podofilox. Four suppliers are listed for this compound.

Summary for Generic Name: podofilox

Tradenames:2
Patents:0
Applicants:3
NDAs:4
Drug Master File Entries: see list2
Suppliers / Packagers: see list4
Bulk Api Vendors: see list72
Patent Applications: see list5,656
Therapeutic Class:Dermatological Agents
Drug Prices:see low prices
DailyMed Link:podofilox at DailyMed

Pharmacology for Ingredient: podofilox

Physiological EffectDecreased Mitosis
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan Sales Llc
CONDYLOX
podofilox
SOLUTION;TOPICAL019795-001Dec 13, 1990ATRXYesYes► Subscribe► Subscribe► Subscribe
Allergan Sales Llc
CONDYLOX
podofilox
GEL;TOPICAL020529-001Mar 13, 1997RXYesYes► Subscribe► Subscribe► Subscribe
Bausch And Lomb Inc
PODOFILOX
podofilox
SOLUTION;TOPICAL090184-001Jul 21, 2010ATRXNoNo► Subscribe► Subscribe► Subscribe
Paddock Llc
PODOFILOX
podofilox
SOLUTION;TOPICAL075600-001Jan 29, 2002ATRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: podofilox

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan Sales Llc
CONDYLOX
podofilox
GEL;TOPICAL020529-001Mar 13, 1997► Subscribe► Subscribe
Allergan Sales Llc
CONDYLOX
podofilox
GEL;TOPICAL020529-001Mar 13, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
Queensland Health
Johnson and Johnson
Teva
Dow
US Department of Justice
Chubb
Julphar
Medtronic
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot